Raising capital for a healthcare startup is fundamentally different from fundraising in other sectors. Investors evaluating healthcare companies look beyond product-market fit and revenue growth. They want to know whether your business is built on a legally sound foundation—and compliance is at the center of that evaluation.
Whether you are raising a seed round for a telehealth platform or a Series A for a multi-state clinic network, the compliance posture of your organization directly influences your valuation, your timeline to close, and the terms you can negotiate. Here is how to think about compliance as a fundraising asset, not just a cost center.
What Investors Examine During Due Diligence
Healthcare-focused investors and general VCs with healthcare portfolio companies conduct more rigorous due diligence than in most sectors. Their legal teams will scrutinize several areas before writing a check.
- Corporate structure and CPOM compliance: Is the company properly structured under the corporate practice of medicine doctrine? Does it use an MSO-PC arrangement where required?
- Physician ownership and friendly PC documentation: Who owns the professional corporation? Are the agreements between the MSO and PC properly documented and at fair market value?
- Licensing and credentialing: Are all clinicians properly licensed in the states where the company operates? Is the credentialing process documented?
- HIPAA and data privacy: Does the company have a comprehensive privacy program, including Business Associate Agreements, risk assessments, and incident response plans?
- Anti-kickback and Stark Law exposure: Are physician compensation arrangements, referral relationships, and marketing practices compliant with federal fraud and abuse laws?
Gaps in any of these areas do not just slow down your raise. They can kill the deal entirely or result in significant valuation haircuts.
How MSO-PC Structure Affects Valuation
The MSO-PC model is the standard corporate structure for venture-backed healthcare companies operating in states with CPOM restrictions. In this arrangement, the management services organization (MSO) handles non-clinical business operations while a physician-owned professional corporation (PC) employs the clinicians and holds the clinical licenses.
Investors value the MSO entity, not the PC. The strength of the management services agreement between the two entities is what determines how much economic value flows to the investable entity.
A well-structured MSO-PC arrangement gives investors confidence that the company can scale across state lines, bring on additional physicians, and operate without regulatory disruption. Key valuation factors include:
- Duration and stability of the MSA: Long-term agreements with clear renewal terms are preferred. Short-term or easily terminable agreements create risk.
- Scope of services: The MSA should cover a comprehensive range of administrative, technology, and operational services to justify the management fees.
- Compensation methodology: Management fees must reflect fair market value. Percentage-of-revenue models are common but must be defensible under anti-kickback analysis.
- Physician alignment: Investors want to see that the friendly physician owner is committed, properly vetted, and has a clear succession plan.
Compliance as a Competitive Advantage
Most healthcare founders view compliance as a necessary burden. The smartest founders treat it as a moat. When your compliance infrastructure is mature, you can move faster than competitors who are scrambling to address regulatory issues mid-raise.
Here is what strong compliance positioning looks like in a fundraising context:
- Multi-state readiness: Having a scalable compliance framework that can be deployed to new states demonstrates growth potential without proportional risk.
- Documented policies and procedures: A compliance manual, training records, and audit trails show investors that compliance is operationalized, not just theoretical.
- Proactive monitoring: Ongoing compliance monitoring, including license tracking, regulatory change management, and periodic internal audits, signals operational maturity.
- Clean regulatory history: No enforcement actions, complaints, or unresolved compliance issues. Investors will check.
Companies that can demonstrate these attributes often command higher valuations because they present lower regulatory risk to investors.
Red Flags That Scare Investors Away
Just as strong compliance attracts capital, compliance gaps repel it. Here are the most common red flags that cause investors to walk away from healthcare deals:
- No formal MSO-PC structure in a state that requires one. This suggests either ignorance of the regulatory landscape or intentional non-compliance.
- Verbal or informal physician agreements. If the relationship between the MSO and the PC is not documented in a comprehensive written agreement, investors see existential risk.
- Fee-splitting arrangements that have not been reviewed for anti-kickback compliance. Compensation structures that tie physician pay directly to referrals are a major liability.
- No HIPAA risk assessment. This is a basic requirement under the HIPAA Security Rule, and its absence signals that the company has not taken privacy seriously.
- Operating in multiple states without a state-by-state compliance analysis. Healthcare regulations vary dramatically by state, and a one-size-fits-all approach creates exposure.
Preparing for Your Raise
If you are planning to raise capital in the next six to twelve months, the time to address compliance is now. Investors will find gaps during due diligence, and addressing them under the pressure of an active raise is far more expensive and time-consuming than doing so proactively.
Start by conducting a compliance audit of your corporate structure, physician relationships, licensing, and privacy program. Identify gaps and create a remediation plan with realistic timelines. Work with compliance counsel who understands both healthcare regulations and venture-backed business models.
The goal is not perfection. It is demonstrating to investors that you understand the regulatory landscape, have built your business to operate within it, and have the infrastructure to maintain compliance as you scale.